Serpin A1

Serpin A1

Serpin A1 詳細

Molecule Name
Alpha-1-antiproteinase
分子の別称
SerpinA1,PI,A1A,AAT,PI1,A1AT,MGC9222,PRO2275,MGC23330,alpha1AT,SPAAT
Drug Development Progress
治験薬の数14
市販薬剤の数2
研究&開発段階Approved
ターゲットの別称
Alpha-1-antiproteinase,PRO2209,Serpin Family A Member 1,alpha 1-Antitrypsin,Protease Inhibitor 1 (Anti-Elastase), Alpha-1-Antitrypsin,Alpha-1 Protease Inhibitor,Serpin A1,AAT,PI,Serpin Peptidase Inhibitor Clade A (Alpha-1antiproteinase, Antitrypsin) Member 1,Serine (Or Cysteine) Proteinase Inhibitor, Clade A, Member 1,Alpha-1-Antitrypsin Short Transcript Variant 1C4,Serpin Peptidase Inhibitor Clade A Member 1,Alpha-1-Antitrypsin Null,Alpha-1 Antitrypsin,Alpha-1-Antitrypsin,Alpha1AT,PRO2275,NNIF,A1A,PI1,Epididymis Secretory Sperm Binding Protein,Serpin Peptidase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 1,Serine (Or Cysteine) Proteinase Inhibitor, Clade A (Alpha-1 Antiproteinase, Antitrypsin), Member 1,Alpha-1-Antitrypsin Short Transcript Variant 1C5,A1AT,PRO0684,SPAAT,SERPINA1
バックグランド
Serpin A1 is also known as Alpha-1-antitrypsin (A1AT), serum trypsin inhibitor, alpha-1 proteinase inhibitor (A1PI), AAT, which belongs to the serpin family. Most serpins inactivate enzymes by binding to them covalently, requiring very high levels to perform their function. Like all serine protease inhibitors, A1AT has a characteristic secondary structure of beta sheets and alpha helices. Serpin A1 / A1AT is inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form of SerpinA1 inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin. Serpin A1 / A1AT protects tissues from enzymes of inflammatory cells, especially neutrophil elastase. Defects in SERPINA1 are the cause of alpha-1-antitrypsin deficiency (A1ATD).

Serpin A1 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
FazirsiranTAK-999; ADS-001; ARO-AATPhase 3 ClinicalArrowhead Pharmaceuticals Inc, Takeda Pharmaceutical Co Ltd
alpha 1-Antitrypsin Deficiency; Hepatic Insufficiency
詳細
YOLT-202YOLT-202Phase 3 ClinicalShanghai Yaotang Biotechnology Co Ltd
alpha 1-Antitrypsin Deficiency; Genetic Diseases, Inborn
詳細
Efdoralprin alfaINBRX-101; AT-292; rhAAT-Fc; AAT-IgG-Fc; AAT-Fc; SAR447537; SAR-447537Phase 2 ClinicalArecor Ltd, Inhibrx
alpha 1-Antitrypsin Deficiency; Emphysema
詳細
TSRA-196TSRA-196Phase 2 ClinicalTessera Therapeutics Inc
alpha 1-Antitrypsin Deficiency
詳細
VX-864VX-864Phase 2 ClinicalVertex Pharmaceuticals Incorporated
alpha 1-Antitrypsin Deficiency
詳細
KRRO-110KRRO-110Phase 2 ClinicalKorro Bio Inc
alpha 1-Antitrypsin Deficiency
詳細
WVE-006WVE-006; GSK-5462688Phase 2 ClinicalWave Life Sciences Ltd
alpha 1-Antitrypsin Deficiency
詳細
BEAM-302α1-AD; α-1-AD; BEAM-302Phase 2 ClinicalBeam Therapeutics Inc
alpha 1-Antitrypsin Deficiency
詳細
adeno-associated virus gene therapy (University of Massachusetts/University of Florida/NHLBI)Phase 1 ClinicalUniversity of Massachusetts
alpha 1-Antitrypsin Deficiency
詳細
KB-408KB-408Phase 1 ClinicalKrystal Biotech Inc
alpha 1-Antitrypsin Deficiency
詳細
VX-668VX-668; VX668Phase 1 ClinicalVertex Pharmaceuticals Incorporated
alpha 1-Antitrypsin Deficiency
詳細
VX-634VX-634Phase 1 ClinicalVertex Pharmaceuticals Incorporated
alpha 1-Antitrypsin Deficiency
詳細
BMN-349BMN-349Phase 1 ClinicalBiomarin Pharmaceutical Inc
alpha 1-Antitrypsin Deficiency
詳細
Alpha-1 antitrypsin (Kalytera Therapeutics)ClinicalClalit Health Services
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
Alpha1-proteinase inhibitor (Human, Grifols)TAL-6004ApprovedBayer AG, Grifols SaProlastin, Prolastin-cUnited Statesalpha 1-Antitrypsin Deficiencynull1987-12-02
alpha 1-Antitrypsin Deficiency; Coronavirus Disease 2019 (COVID-19); Cystic Fibrosis; Pancreatitis, Chronic; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema
詳細
Alfalastin (LFB SA)ApprovedLfb Biotechnologies SasAlfalastinFrancealpha 1-Antitrypsin DeficiencyLfb Biotechnologies Sas2005-08-01
alpha 1-Antitrypsin Deficiency
詳細